Cardiac Biotech Solutions Inc. (CBSC)
Cardiac Biotech Solutions Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $4.0M. On trailing twelve-month figures it carries a trailing P/E of -4.29, a net margin of -594.5%. Its beta of 1.90 implies it has historically moved more than the broad market.
Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms. These solutions are designed to boost patient engagement for individuals prone to irregular heart rhythms, simultaneously providing medical professionals with highly accurate diagnostic insights. Furthermore, its wholly owned U.S. subsidiary, My-Cardia (USA), Inc., focuses on creating wearable ECG recording devices that patients can utilize in an ambulatory setting for periods extending up to 30 days.
Cardiac Biotech Solutions Inc. is most often compared with the following Healthcare names: